<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04098172</url>
  </required_header>
  <id_info>
    <org_study_id>S2434</org_study_id>
    <nct_id>NCT04098172</nct_id>
  </id_info>
  <brief_title>Evaluate the Performance and Safety of Comet Pressure Guidewire in the Measurement of FFR</brief_title>
  <official_title>A Prospective, Multicenter Study to Evaluate the Performance and Safety of CometTM Pressure Guidewire in the Measurement of FFR in Chinese Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, open-label, multi-center study designed to validate the agreement of CometTM
      Pressure Guidewire and Pressure Wire Certus® in FFR measurements
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 3, 2019</start_date>
  <completion_date type="Actual">March 11, 2020</completion_date>
  <primary_completion_date type="Actual">March 11, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Acceptable agreement between CometTM Pressure Guidewire and Pressure Wire Certus® in FFR measurements</measure>
    <time_frame>during procedure</time_frame>
    <description>The mean paired difference is within +/- 0.005 #
The limits of agreement (defined as the mean observed difference +/- 1.96* observed SD) is within the pre-defined agreement limits of [-0.08, 0.08] #</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">39</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <arm_group>
    <arm_group_label>Pressure Guidewire test subject</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Stable patients with suspected or known CAD, who are scheduled for diagnostic angiography and pressure wire assessment, and signed the informed consent, will be screened for enrollment in this study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pressure Guidewire</intervention_name>
    <description>Fractional Flow Reserve measurement</description>
    <arm_group_label>Pressure Guidewire test subject</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        General Inclusion Criteria:

          1. Patient must be at least 18 years old and less than or equal to 75 years of age

          2. Patient or his/her legally-authorized representative agrees to sign the EC-approved
             ICF prior to the procedure

          3. Patient with stable angina or any form of non-ST elevation acute coronary syndrome and
             is clinically indicated of intra-coronary diagnostic angiography and FFR assessment

        Angiographic Inclusion Criteria:

        Moderate stenosis (30% to 70% diameter stenosis by visual estimation) is detected at
        diagnostic angiography

        General Exclusion Criteria:

          1. Patients unable to provide informed consent

          2. Patients in pregnant state

          3. Known renal insufficiency or failure (serum creatinine level of &gt; 2.5 mg/dL, or on
             dialysis)

          4. Allergy to the contrast

          5. Significant arrhythmia, such as II degree or above of atrioventricular block, Sick
             sinus syndrome, ventricular tachycardia

          6. Spastic bronchial asthma

          7. ST elevation coronary syndrome

          8. Hemodynamic instability

          9. Contraindication to nitroglycerin or ATP

         10. Current participation in another investigational drug or device clinical study that
             may affect the FFR measurements

        Angiographic Exclusion Criteria:

        CTO lesion Severe vessel tortuosity at the stenotic segments Culprit vessel of
        non-ST-segment elevation acute myocardial infarction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The First Affilited Hospital of Xi,an Jiaotong University</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710061</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The General Hospital of Tianjin Medical University</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <zip>300052</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>February 3, 2019</study_first_submitted>
  <study_first_submitted_qc>September 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 23, 2019</study_first_posted>
  <last_update_submitted>June 28, 2020</last_update_submitted>
  <last_update_submitted_qc>June 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

